{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_198578.4:c.4321C>T",
          "cDNA Change": {
            "transcript": "NM_198578.4",
            "ref": "C",
            "alt": "T",
            "position": "4321"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C mutation in the ROC domain"
        },
        {
          "HGVS": "NM_198578.4:c.6055G>A",
          "cDNA Change": {
            "transcript": "NM_198578.4",
            "ref": "G",
            "alt": "A",
            "position": "6055"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S mutation in the kinase domain"
        },
        {
          "HGVS": "NM_198578.4:c.6059T>C",
          "cDNA Change": {
            "transcript": "NM_198578.4",
            "ref": "T",
            "alt": "C",
            "position": "6059"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "2020"
          },
          "Description in input context": "I2020T mutation in the kinase domain"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005180"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro Phosphorylation Assay",
      "Material used": {
        "Material Source": "Recombinant Proteins",
        "Material Name": "Recombinant human Akt1 and LRRK2",
        "Description": "One hundred nanograms of recombinant human Akt1 (His-tagged protein) was incubated with 50 ng of recombinant human LRRK2 (GST-tagged protein consisting of amino acid residues 970-2527; either wildtype, R1441C mutant, G2019S mutant, or I2020T mutant)."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.4321C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "R1441C mutant LRRK2 exhibited significantly weaker kinase activity for Akt1 (Ser473) phosphorylation compared to wild-type LRRK2."
        },
        {
          "Variant": "NM_198578.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "G2019S mutant LRRK2 showed diminished kinase activity toward Akt1 (Ser473), ascribable to impaired Akt1-binding ability."
        },
        {
          "Variant": "NM_198578.4:c.6059T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "I2020T mutant LRRK2 exhibited significantly weaker kinase activity for Akt1 (Ser473) phosphorylation compared to wild-type LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control for phosphorylation activity."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation level of Akt1 (Ser473) comparable to wild-type LRRK2 activity.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation level of Akt1 (Ser473) significantly lower than wild-type LRRK2 activity (p < 0.005).",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "GST Pull-down Assay",
      "Material used": {
        "Material Source": "Recombinant Proteins",
        "Material Name": "Recombinant GST-LRRK2 and His-Akt1",
        "Description": "Recombinant GST-LRRK2 or GST alone was mixed with the recombinant His-Akt1 and incubated with glutathione agarose beads."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.4321C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "R1441C mutant LRRK2 showed reduced binding ability to Akt1 compared to wild-type LRRK2."
        },
        {
          "Variant": "NM_198578.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "G2019S mutant LRRK2 exhibited significantly impaired binding ability to Akt1."
        },
        {
          "Variant": "NM_198578.4:c.6059T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "I2020T mutant LRRK2 showed reduced binding ability to Akt1 compared to wild-type LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type GST-LRRK2 was used as a positive control for binding activity."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "GST alone was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Binding level of Akt1 to LRRK2 comparable to wild-type LRRK2.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Binding level of Akt1 to LRRK2 significantly lower than wild-type LRRK2.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Western Analysis",
      "Material used": {
        "Material Source": "Cell line and Recombinant Proteins",
        "Material Name": "SH-SY5Y cells and Recombinant Proteins",
        "Description": "Proteins after in vitro phosphorylation and those in cell lysates from SH-SY5Y cells were subjected to SDS-PAGE and blotted for analysis using specific antibodies."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.4321C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "R1441C mutant LRRK2 exhibited reduced phosphorylation of Akt1 at Ser473 compared to wild-type LRRK2."
        },
        {
          "Variant": "NM_198578.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "G2019S mutant LRRK2 showed diminished phosphorylation of Akt1 at Ser473."
        },
        {
          "Variant": "NM_198578.4:c.6059T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "I2020T mutant LRRK2 exhibited reduced phosphorylation of Akt1 at Ser473 compared to wild-type LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control for phosphorylation levels."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation level of Akt1 (Ser473) comparable to wild-type LRRK2 activity.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation level of Akt1 (Ser473) significantly lower than wild-type LRRK2 activity (p < 0.005).",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "LRRK2 Knockdown Experiment",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y cells",
        "Description": "Neuroblastoma SH-SY5Y cells were transfected with LRRK2-specific RNAi for knockdown experiments."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.4321C>T",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Specific results for R1441C mutant in knockdown experiments not described in the literature."
        },
        {
          "Variant": "NM_198578.4:c.6055G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Specific results for G2019S mutant in knockdown experiments not described in the literature."
        },
        {
          "Variant": "NM_198578.4:c.6059T>C",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Specific results for I2020T mutant in knockdown experiments not described in the literature."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "RNAi control was used as a positive control for comparison."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation level of Akt1 (Ser473) comparable to control RNAi cells.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation level of Akt1 (Ser473) reduced to 51% or lower compared to control RNAi cells.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}